Editorial Commentary
Light on the horizon for HER2 overexpressing non-small cell lung cancer?
Translational Lung Cancer Research
2025;
14
(2)
:305-309
.
(28 February 2025)
Alectinib impressively enters the adjuvant setting for early-stage ALK-rearranged non-small cell lung cancer and outperforms chemotherapy—let’s define who benefits the most
Translational Lung Cancer Research
2025;
14
(2)
:310-313
.
(28 February 2025)
Trastuzumab deruxtecan in HER2 overexpressing non-small cell lung cancer (NSCLC)
Translational Lung Cancer Research
2025;
14
(2)
:314-322
.
(28 February 2025)
Will “Sun”-WUKONG, the monkey king, conquer EGFR exon 20 insertion mutation positive non-small cell lung cancer?
Translational Lung Cancer Research
2025;
14
(2)
:323-327
.
(28 February 2025)
Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?
Translational Lung Cancer Research
2025;
14
(2)
:328-333
.
(28 February 2025)
Sunvozertinib: shining light on lung cancer’s exon 20 fight
Translational Lung Cancer Research
2025;
14
(2)
:334-340
.
(28 February 2025)
Original Article
Study of the radiologic and pathologic correlations for subsolid lung adenocarcinoma with the application of whole-mount sections (ECTOP1011)
Translational Lung Cancer Research
2025;
14
(2)
:341-352
.
(28 February 2025)
Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study
Translational Lung Cancer Research
2025;
14
(2)
:353-362
.
(28 February 2025)
Comparison of metastasis and treatment patterns among different histopathologic types of lung cancer: analysis of 6 years of nationwide lung cancer cohort data in Korea
Translational Lung Cancer Research
2025;
14
(2)
:363-384
.
(28 February 2025)
Dual-layer spectral detector computed tomography multiparameter machine learning model for prediction of invasive lung adenocarcinoma
Translational Lung Cancer Research
2025;
14
(2)
:385-397
.
(28 February 2025)
Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(2)
:398-407
.
(28 February 2025)
Sleeve lobectomy versus lobectomy after neoadjuvant chemo-immunotherapy for non-small cell lung cancer invading the lobar bronchial orifice: a multicenter retrospective cohort study
Translational Lung Cancer Research
2025;
14
(2)
:408-421
.
(28 February 2025)
Immunotherapy efficacy between exon 19 deletion and exon 21 L858R mutation in advanced EGFR mutant non-small-cell lung cancer: a direct and indirect meta-analysis
Translational Lung Cancer Research
2025;
14
(2)
:422-430
.
(28 February 2025)
Spectral dual-layer detector CT-based radiomics-deep learning for predicting pathological aggressiveness of stage I lung adenocarcinoma: discrimination of precursor glandular lesions and invasive adenocarcinomas
Translational Lung Cancer Research
2025;
14
(2)
:431-448
.
(28 February 2025)
Whole-section digital analysis of immune profiles in surgically resected small cell lung carcinoma and their associations with molecular subtypes
Translational Lung Cancer Research
2025;
14
(2)
:449-466
.
(28 February 2025)
Real-world comparison of neoadjuvant pembrolizumab plus chemotherapy versus tislelizumab plus chemotherapy in patients with resectable non-small cell lung cancer: a retrospective cohort study of treatment outcomes
Translational Lung Cancer Research
2025;
14
(2)
:467-479
.
(28 February 2025)
Dual-phase computed tomography imaging for lung function assessment in patients with early-stage non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(2)
:480-490
.
(28 February 2025)
Aspirin impedes non-small cell lung cancer development via fine-tuning the CD36 localization regulated by GPIHBP1
Translational Lung Cancer Research
2025;
14
(2)
:491-512
.
(28 February 2025)
Clinical application of three-dimensional reconstruction in anatomical analysis of the right anterior, lateral, and posterior basal segments (RS8, RS9, and RS10) for RS9 segmentectomy
Translational Lung Cancer Research
2025;
14
(2)
:513-525
.
(28 February 2025)
Clinical-genomic nomogram for predicting sensitivity to second-line immunotherapy for advanced non-small cell lung cancer
Translational Lung Cancer Research
2025;
14
(2)
:526-537
.
(28 February 2025)
Efficacy of neoadjuvant immunochemotherapy in the treatment of stage III non-small-cell lung cancer with cancer driver gene mutations
Translational Lung Cancer Research
2025;
14
(2)
:538-551
.
(28 February 2025)
Risk factors for postoperative pulmonary complications in non-adenocarcinoma non-small cell lung cancer patients undergoing surgery after neoadjuvant therapy
Translational Lung Cancer Research
2025;
14
(2)
:552-562
.
(28 February 2025)
Comparative outcomes of first-line PD-1/PD-L1 inhibitors plus chemotherapy for advanced squamous non-small cell lung cancer: a systematic review and network meta-analysis of randomized clinical trials
Translational Lung Cancer Research
2025;
14
(2)
:563-574
.
(28 February 2025)
Review Article
Lung cancer organoids: a new strategy for precision medicine research
Translational Lung Cancer Research
2025;
14
(2)
:575-590
.
(28 February 2025)
Radiotherapy as salvage therapy and an adjunct to immunotherapy: exploring local and abscopal mechanisms to overcome immunotherapy resistance: a narrative review
Translational Lung Cancer Research
2025;
14
(2)
:591-606
.
(28 February 2025)
Case Report | iMDT Corner
Cerebrospinal fluid cytology for the diagnosis of lung cancer brain metastasis: a case report
Translational Lung Cancer Research
2025;
14
(2)
:607-613
.
(28 February 2025)
Case Report
Pathologic complete response following salvage surgery after lazertinib treatment in advanced EGFR-mutated lung adenocarcinoma: case report and literature review
Translational Lung Cancer Research
2025;
14
(2)
:614-618
.
(28 February 2025)
Ion robotic bronchoscopy laser ablation and Da Vinci robotic segmentectomy for bilateral pulmonary nodules: a case report
Translational Lung Cancer Research
2025;
14
(2)
:619-624
.
(28 February 2025)
Novel LZTR1 germline mutation as a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma: a case report
Translational Lung Cancer Research
2025;
14
(2)
:625-630
.
(28 February 2025)
Partial response to lorlatinib in thoracic inflammatory myofibroblastic tumor harboring complex and rare ALK fusions: a case report
Translational Lung Cancer Research
2025;
14
(2)
:631-638
.
(28 February 2025)
Unravelling the complexity of EGFR-mutated lung adenocarcinoma: a unique case report with histological transformations and co-alteration acquisition
Translational Lung Cancer Research
2025;
14
(2)
:639-648
.
(28 February 2025)
Letter to the Editor
Learning from chronic disease screening success: developing efficient, convenient, and affordable lung cancer screening methods to achieve universal coverage
Translational Lung Cancer Research
2025;
14
(2)
:649-651
.
(28 February 2025)
Erratum
Erratum: Tumor cavitation in patients with non-small-cell lung cancer receiving anti-angiogenic therapy with apatinib
Translational Lung Cancer Research
2025;
14
(2)
:652
.
(28 February 2025)
